--- Chain 2 for Question 158 ---
Status: COMPLETED
Is Active Flag: True
Finish Reason: stop
Reasoning Complete Flag: True
Error: None
Prompt Tokens: 210
Completion Tokens: 6516
Completed Thoughts: 3
Accumulated Pruned Count: 9
Final Mean Pairwise Similarity: 0.6758
Final Internal Similarity: 0.2253
Final Processed Boundaries: [0, 2582, 3346]

--- Full Content ---
Okay, so I have this question about transcription factors and mutations. Hmm, I remember that transcription factors help turn specific genes on or off by binding to nearby DNA. The question is about what happens when certain mutations occur in different domains of the transcription factor.

So the scenario is that there's a transcription factor subunit in an inactive state. It needs to get activated by a signal from the membrane through a phosphorylation cascade. Once it's phosphorylated on serine residues in the transactivation domain, it dimerizes, moves into the nucleus, and helps with gene transcription.

Now, the question is about two mutations. Mutation X is a missense mutation in the transactivation domain and it's a recessive loss-of-function mutation. That means, I think, that the mutation alone doesn't cause a problem because it's recessive. So both alleles need to be mutated for the effect to be seen. Since it's loss-of-function, maybe the transactivation domain isn't working right, so the protein can't dimerize or move into the nucleus properly.

Then there's mutation Y, which is a heterozygous mutation in the dimerization domain. It's a dominant-negative mutation. Dominant negative usually means that the mutated protein interferes with the normal function of the wild-type protein. Since it's heterozygous, only one allele is mutated, but the mutation is dominant, so it affects the function.

The question is, what molecular phenotype do we observe when mutation Y is present? The options are A to D.

So, thinking about how dominant-negative mutations work. In this case, the transcription factor probably forms dimers because they need to dimerize to function. If one subunit has a mutation in the dimerization domain, it can't form the correct interactions. But since it's dominant-negative, that defective subunit might interfere with the wild-type subunit from forming the dimer correctly.

So, if the mutant Y subunit is in the dimerization domain and is dominant-negative, when it forms a dimer with a wild-type subunit, the dimer might not function properly. Or even if the mutant can't dimerize, maybe it prevents the wild-type from doing so because it's in the same domain.

In the scenario, the wild-type would dimerize, move to the nucleus, and help in transcription. But with mutation Y, that process might be disrupted.

Looking at the options:

Option A: Change of conformation and gain of function. I don't think so. Dominant-negative usually causes loss of function, not gain.

Option B: Protein degradation and loss of wild-type. Wait, heterozygous means one wild and one mutant allele. If the mutant Y somehow causes degradation, would that affect the wild-type? Maybe if the mutant Y binds to the wild-type protein and leads it to be degraded. But I'm not sure if that's the primary mechanism here.

Option C: Loss of dimerization and wild-type phenotype. No, because if the dimer can't form, the function is lost. So the phenotype wouldn't be wild-type.

Option D: Aggregation and loss of function. Aggregation suggests that the proteins form insoluble clumps. If Y causes the protein to misfold and aggregate, they might not function. But dominant-negative can cause this. Alternatively, maybe Y prevents proper dimer formation, leading to proteins not functioning, thus loss of function.

Wait, how does dominant-negative work here? Let me think. Dominant-negative mutations usually interfere with the function of the protein by disrupting its structure or interactions. So if Y is in the dimerization domain, when the mutant Y protein is produced (from one allele), it might form a dimer with the wild-type subunit but not properly. This could prevent the activation step because the dimer is non-functional. Alternatively, the mutant might sequester the wild-type, making it unavailable for proper function.

So in the presence of mutation Y, the transcription factor can't dimerize properly. Therefore, even if the wild-type allele is functional, the mutant allele's product is interfering, making the overall protein not function. So the result is a loss of function. So the molecular phenotype would be that the proteins can't dimerize, leading to loss of function.

Looking again at the options, which one matches that?

Option B says protein degradation and loss of wild-type. But if the mutant Y is dominant-negative, perhaps it doesn't lead to degradation. It just disrupts function.

Option D: Aggregation and loss of function. That would be if the proteins form aggregates, but I'm not sure if that's the case here. The question says that Y is a dominant-negative, which usually doesn't cause aggregation but disrupts function by preventing proper interactions.

So in the case of Y, which is in the dimerization domain, the mutant Y might prevent the protein from dimerizing. So the dimerization doesn't happen, leading to the inability to move into the nucleus and activate transcription. Thus, the phenotype would be a loss of function.

Looking at the options again:

Option B: Protein degradation and loss of wild-type. I think this is more about when a mutant protein is broken down, but I don't know if Y leads to that.

Option D: Aggregation and loss of function. Maybe, but I'm not certain.

Alternatively, another possibility is that the mutant Y can't form dimers, but when it's a dominant-negative, the presence of Y might cause the wild-type to not form dimers either.

Wait, the question says that Y is a dominant-negative mutation in the dimerization domain. So when the transcription factor is supposed to dimerize, the Y mutant prevents it. So the result is that the transcription factor can't form the dimer and thus can't function.

So the phenotype would be a loss of function. Now, looking at the options:

Option B: Protein degradation and loss of wild-type. If Y caused the proteins to be degraded, then the wild-type wouldn't function, leading to loss.

But why would Y cause degradation? I'm not sure. Maybe if the mutant Y is not properly folded, the cell's quality control degrades it. But if it's dominant-negative, perhaps the mutant Y somehow inhibits the wild-type's ability to function without necessarily degrading the proteins.

Wait, the question is about molecular phenotype. So what's happening at the molecular level?

If Y is dominant-negative, it probably disrupts the proper folding or function of the protein. So when the heterozygous individual (who has one wild-type and one Y mutant allele) produces the transcription factor, the mutant Y might interfere with the function of the wild-type.

Looking at the options:

Option B says protein degradation. So the mutant Y is leading to the breakdown of the protein. But I don't see why Y would cause degradation. Unless the mutant is somehow targeted for the proteasome.

Alternatively, maybe the presence of Y leads to misfolding, and the cell's quality control tags it for degradation. But the wild-type would still be produced. But if the mutant is dominant-negative, perhaps it somehow affects the wild-type's stability.

Wait, but the question states that the mutation Y is in the dimerization domain. So, the mutant Y may not be able to form a dimer. If the transcription factor is a homodimer, then if one subunit is mutant, the dimer can't form. But since the person is heterozygous, each cell has 50% of each allele. So, in some cells, more mutant Y proteins are produced, leading to a dominant-negative effect.

Alternatively, when the mutant Y subunits are produced, they might form non-functional dimers with wild-type subunits, preventing the wild-type from functioning.

So, the molecular outcome is that the dimer can't form properly. So the protein can't shuttle into the nucleus, and gene transcription doesn't occur.

Looking at the options:

Option B: Does this involve protein degradation? Maybe not necessarily.

Option D: Protein aggregation. Maybe if the mutant Y causes the proteins to misfold and aggregate, but I don't think that's the primary effect here. The main issue is dimerization.

Wait, the options are about the molecular phenotypes. So, in the presence of Y, what happens?

The Y mutation is in the dimerization domain and is dominant-negative. So the presence of Y would prevent the transcription factor from dimerizing, leading to the failure to transactivate genes. So the phenotype is loss of function.

So looking at the options, which option says that the dimer doesn't form and function is lost.

Option B: Protein degradation and loss of wild-type. If the mutant Y causes the proteins to be degraded, then wild-type proteins are lost. But I don't see why Y would cause degradation. Alternatively, maybe the mutant Y is not degraded but is non-functional.

Option C: Loss of dimerization and wild-type phenotype. No, because if dimerization is lost, the function is lost, so the phenotype would be loss-of-function, not wild-type.

Option D: Aggregation and loss. Maybe, but not certain.

Wait, the question is about the presence of mutation Y. So the person is heterozygous for Y; their genotype is wild-type and Y.

But the Y is dominant-negative, so the presence of Y allele causes the dominant-negative effect. So the presence of Y would lead to the transcription factor not functioning.

Which molecular effect would that be?

In the presence of Y, the proteins can't dimerize. So the dimerization is lost.

Looking at the options, the only option that mentions loss of dimerization is option B? Wait, no. Let me check options again.

Option B: protein degradation and loss of wild-type.

Option C: loss of dimerization and wild-type phenotype.

Wait, option C says loss of dimerization and wild-type phenotype. But if dimerization is lost, the function is lost, which would lead to a loss-of-function phenotype, not wild-type. So C is incorrect.

Option D: protein aggregation and loss.

Hmm, perhaps the proteins can't form functional dimers, so they aggregate, leading to loss of function.

But I'm not sure. Alternatively, perhaps the mutant Y protein can't dimerize, so it's non-functional, but the wild-type protein is okay. But since it's dominant-negative, it would interfere with the wild-type. So in a cell with both wild-type and Y, the Y would prevent the wild-type from functioning, leading to overall loss.

So, the phenotype is loss of function.

Looking at options, the correct molecular effect would be that the proteins can't dimerize, leading to loss of function.

Which options include loss of dimerization and loss of function?

Option B doesn't mention dimerization. Option D doesn't mention it either.

Wait, the options:

A) conformation change, gain

B) degradation, loss

C) loss of dimerization, wild-type (unlikely)

D) aggregation, loss

Wait, none of the options directly mention loss of dimerization. So maybe I need to think in terms of whether the dimerization is prevented. If Y is dominant-negative, then the presence of Y would prevent the dimer from forming.

Wait, the question is about the molecular phenotype. So the molecular effect would be that the protein can't dimerize, leading to loss of function.

So the options don't directly state that, but perhaps we can infer.

Option B: protein degradation and loss of wild-type. If Y's presence leads to the wild-type proteins being broken down, then that would cause loss of function. But I'm not sure if dominant-negative mutations cause degradation of the wild-type.

Alternatively, perhaps the mutant Y doesn't interfere directly with dimerization but affects the ability to be phosphorylated. But the question says Y is in the dimerization domain.

Wait, in the question, X is in the transactivation domain. Y is in the dimerization domain.

So, for the wild-type, when it's activated, it dimerizes. If Y is a dominant-negative in the dimerization domain, the mutant Y subunits might prevent the wild-type subunits from dimerizing correctly.

So, the mutant Y would prevent the dimerization, leading to the transcription factor not functioning. So the phenotype would be loss of function.

Looking again at the options, which one indicates a loss of function?

Option B: protein degradation and loss of wild-type. If the presence of Y leads to the wild-type being degraded, then that would cause loss of function.

Alternatively, perhaps the mutant Y doesn't allow the dimer to form, so the protein doesn't move to the nucleus.

But the options don't directly describe that. So which option fits best?

Option D: aggregation and loss. If the mutant Y causes the proteins to aggregate, that would lead to non-functional proteins, so loss of function.

Alternatively, perhaps the presence of Y leads to the protein not dimerizing, so it doesn't enter the nucleus, but that's not one of the options.

Wait, the question is about the molecular phenotype, so what is happening at the molecular level.

If Y is a dominant-negative mutation in the dimerization domain, the mutant Y subunits would prevent the proper dimer formation. So the dimer can't form, leading to the inability to function.

So, the proteins can't dimerize, which is a molecular phenotype. Looking at the options, none of them directly say that, but perhaps option B or D are more about what happens beyond dimerization.

Wait, perhaps the absence of dimerization leads to the protein being marked for degradation. So the proteins don't dimerize, so they're not transported to the nucleus, and perhaps are recognized as misfolded and degraded.

If that's the case, then the presence of mutation Y leads to protein degradation.

So, option B says protein degradation and loss of wild-type. But why would the wild-type be lost? Because the mutant Y is causing the wild-type proteins to be degraded?

Alternatively, perhaps the mutant Y proteins are not properly folded and are degraded, but the wild-type proteins are okay.

But in a dominant-negative situation, the mutant Y would be expressed and interfere with the wild-type. So perhaps Y causes the wild-type proteins to be non-functional, but not necessarily degraded.

Alternatively, if the mutant Y cannot dimerize, it might form aggregates (misfolded proteins), leading to its degradation. But the wild-type proteins would still be functional, unless they're sequestered by the mutant Y.

Wait, but the question says that when Y is present, the phenotype is observed. So the presence of Y would lead to a loss of function.

Looking at the options, perhaps the best fit is option B: protein degradation and loss of wild-type. But I'm not entirely sure.

Alternatively, perhaps the mutant Y doesn't allow the dimerization, so the proteins cannot enter the nucleus. But that would be more about localization, not a molecular phenotype described in the options.

Alternatively, in the presence of Y, the dimerization domain is faulty, so the transcription factor doesn't dimerize, so it can't activate the genes. So the phenotype is loss of function.

So, the options:

Option B: protein degradation and loss of wild-type. Hmm. If the protein is not dimerizing, perhaps it's not functioning but remains in the cytoplasm. But the option says protein degradation, which I'm not certain about.

Option D: protein aggregation and loss. If the mutant Y causes the proteins to aggregate, then they can't function and are perhaps not available for their normal function. That could lead to loss of function.

Alternatively, another possibility is that the mutant Y doesn't dimerize, so the protein can't move to the nucleus, but it doesn't get degraded. So the mutation Y would cause the proteins to remain in the cytoplasm, leading to loss of function. But the options don't reflect that.

Wait, the question is about the presence of mutation Y. The options are about the molecular phenotype, so what is happening to the proteins.

If Y is dominant-negative in the dimerization domain, then the presence of Y would lead to:

- The mutant Y protein cannot form dimers.

- The mutant Y might bind to wild-type proteins, preventing their proper dimerization.

So, in the presence of Y, the proteins cannot form functional dimers, leading to a loss of function.

Which option reflects this?

Looking at the options, none of them directly mention loss of dimerization. So perhaps the best fit is option B.

Wait, but option B says "protein degradation and loss of wild-type allele's function." Maybe mutation Y leads to the degradation of the mutant Y and wild-type proteins, but that's not how dominant-negative typically works.

Alternatively, perhaps the mutant Y doesn't get degraded, but the wild-type does. But I'm not sure.

Alternatively, perhaps the mutant Y can't be phosphorylated, so it can't function, but that's in the transactivation domain. The question is about dimerization.

Hmm, I'm a bit stuck. Let me think again.

In a dominant-negative situation, the mutant protein disrupts the function of the wild-type. If Y is in the dimerization domain, then when the mutant Y is expressed (as in a heterozygous condition), it forms non-functional dimers with the wild-type, preventing the wild-type from functioning.

So the molecular phenotype would be the inability to dimerize, leading to loss of function.

Looking at the options, which one reflects the inability to dimerize, hence loss of function?

Well, none directly, but perhaps option B or D.

Alternatively, perhaps the proteins can't dimerize, so they don't move into the nucleus. But the question is about the molecular phenotype, not the localization.

Wait, the options are more about the structural or degradation changes. So, if the proteins can't dimerize, perhaps they form aggregates or are misfolded, leading to degradation.

If that's the case, then the proteins would be degraded (option B) or aggregate (option D).

Which is more likely? I think sometimes dominant-negative mutations can lead to improper folding, which may cause the proteins to be targeted for degradation via the proteasome. So, that would lead to less functional protein.

If Y causes the proteins to degrade, then the wild-type function is lost. So option B could be the answer.

But I'm not entirely confident. Another angle: dominant-negative often results in the loss of function because the mutant interferes with the wild-type. So the presence of Y would mean that even the wild-type allele's product can't function because it's being inhibited by Y.

So the molecular outcome is that the dimer can't form, leading to loss of function.

Looking at the options:

Option B: protein degradation and loss. Perhaps the mutant Y and wild-type can't form dimers, leading to degradation of the proteins.

Option D: aggregation and loss.

Hmm, I'm a bit torn. But I think the main effect is that the dimerization is prevented, which option B doesn't directly address, but option D talks about protein aggregation, which is a possible outcome of misfolded proteins.

Wait, another thought: if the dimerization is prevented, the proteins might not be properly folded, leading them to aggregate, thus causing a loss of function. So that would be option D.

Alternatively, if the proteins can't dimerize, they might be recognized as misfolded and targeted for degradation, which is option B.

So which is it?

I think in dominant-negative cases, the primary effect is not on the degradation but on the proper functioning through dimerization. So the presence of Y would stop dimerization, leading to the proteins not functioning. So the molecular phenotype is the loss of dimerization, which would lead to the inability to function. Since the options don't have that, perhaps the best fit is option B or D.

Alternatively, perhaps the proteins are not degraded but just fail to function. But the options don't have that.

Wait, the options are about the molecular phenotypes, so perhaps the presence of Y doesn't cause the proteins to be degraded but makes them unable to function.

But in that case, the molecular phenotype is that the proteins can't dimerize, leading to loss of function.

But the options don't have that.

Wait, perhaps in the case of dominant-negative mutations in the dimerization domain, the mutant Y proteins can't form dimers, so the wild-type proteins are not available to form functional dimers with each other. Hence, the dimerization is prevented, which leads to loss of function.

So, the proteins can't dimerize, leading to loss of function.

Looking at the options, the only one that includes loss of function is options B, D, and possibly A.

Wait, option B says loss of function due to degradation. Option D says loss due to aggregation.

Which is more likely? Well, if the Y mutation leads to the dimerization domain being non-functional, the proteins can't form the dimer, so they might not be properly folded. The cell's quality control might mark them for degradation. So the proteins would be degraded, leading to loss of function. If the proteins are degraded, then the wild-type's function is lost because they can't form the dimers, and the mutant proteins are also broken down.

So option B says "protein degradation and loss of wild-type." But if the mutant Y is dominant-negative, it might cause the wild-type proteins to be non-functional without necessarily being degraded.

Alternatively, perhaps the presence of Y leads to the mutant and wild-type proteins being part of non-functional aggregates, leading to their degradation.

Alternatively, perhaps the dimerization is required for the protein's stability. So if the proteins can't dimerize, they might be subject to degradation.

In that case, the presence of Y would lead to the proteins being degraded because they can't form the proper structure, leading to loss of function.

So, if that's the case, the correct option would be B: protein degradation and loss of wild-type function.

But I'm a bit confused because dominant-negative usually doesn't cause degradation, but disrupts function.

Wait, another approach: the wild-type protein is functional only when it dimerizes. If Y prevents dimerization, the wild-type proteins can't function, leading to loss of function.

But the proteins themselves aren't necessarily degraded. So the molecular phenotype is the inability to dimerize, but the options don't directly reflect that.

So perhaps the best option is D: protein aggregation and loss of function. If the proteins can't dimerize, perhaps they form aggregates, leading to loss of function.

Alternatively, perhaps the proteins are not aggregated but just non-functional.

Hmm, but the options don't have that. So perhaps the correct answer is B: protein degradation.

Wait, let me think of another angle. In dominant-negative mutations, the mutant protein often disrupts the function of the wild-type by forming non-functional complexes. So in this case, the mutant Y in the dimerization domain would form dimers that don't function, which would lead to the failure of the transcription factor to activate gene expression.

So, the molecular phenotype would be the inability to form functional dimers, leading to loss of function.

Looking back at the options, none directly mention dimerization failure. So perhaps the intended answer is option B or D.

Alternatively, perhaps the dominant-negative mutation Y leads to the mutant proteins being unable to form dimers, and thus the wild-type proteins can't form dimers either because they're being outcompeted by the mutant Y.

But what's the molecular effect? So the transcription factor can't dimerize, so it doesn't enter the nucleus, leading to loss of function.

In terms of the molecular phenotype, perhaps the proteins are not dimerizing, leading to a loss of function.

So the correct answer is probably option B or D.

Wait, I'll try to eliminate options:

Option A: Gain of function. No, dominant-negative is loss of function.

Option C: Wild-type phenotype. No, the presence of Y would cause a loss.

So between B, D, and perhaps another.

Option B: protein degradation and loss of function.

If the proteins are getting degraded, then the transcription factor isn't present. So for the presence of Y, the proteins are being broken down, leading to loss of function.

Alternatively, if the mutant Y doesn't allow the proteins to dimerize, so they can't be transported into the nucleus. But the proteins are still present, just not functioning.

So, the molecular phenotype would not involve protein degradation but rather the failure to function.

So, perhaps the correct answer is B: protein degradation and loss of wild-type. Or D: aggregation and loss.

Wait, considering that dominant-negative mutations can lead to misfolded proteins which are either degraded or aggregate.

In this case, the Y mutation is in the dimerization domain. So the mutant Y proteins can't form the correct dimers, leading to misfolded proteins that might be targeted for degradation.

So option B would be correct, because the presence of Y leads to the proteins being degraded, leading to loss of function.

But wait, why would the presence of Y cause the proteins to be degraded? Because when Y is expressed, the mutant protein is produced and perhaps is recognized as misfolded, leading to its degradation. However, in a heterozygous condition, the other allele is wild-type, so some wild-type proteins are present. But if Y's mutant protein is dominant-negative, perhaps it prevents the wild-type from functioning, but the wild-type might not be degraded.

Alternatively, perhaps the presence of Y leads to the mutant and wild-type proteins being unable to dimerize, and thus the mutant Y is recognized as misfolded and degraded, but the wild-type proteins remain but can't function because they can't dimerize.

I'm not entirely sure, but I'll have to choose the best option.

Based on the options, I think the correct answer is B: protein degradation and loss of wild-type function.

Wait, no, because the presence of Y would affect the function without necessarily causing degradation. So perhaps the proteins are not degraded but are just non-functional.

But the options don't have that.

Hmm, perhaps the intended answer is B. But I'm not entirely confident.

Wait, another angle: In a dominant-negative mutation, the mutant protein might interfere with the function of the wild-type protein. So, for example, if the mutant Y can't dimerize, it might sequester the wild-type proteins, preventing them from dimerizing correctly.

In such a case, the wild-type proteins can't form functional dimers, so they might not be able to perform their function.

But what happens to the wild-type proteins? Are they degraded? Or do they remain in the cytoplasm?

If the wild-type can't dimerize, perhaps they are not degraded but just don't function.

But the options don't reflect that. So perhaps the intended answer is option B, which includes degradation.

Alternatively, the mutant Y's presence leads to the wild-type protein being unable to function and perhaps being targeted for degradation.

Hmm.

I'm going to make a choice. I think that the dominant-negative mutation Y would prevent the dimerization, leading to the proteins not functioning. So the molecular phenotype is a loss of function due to the inability to dimerize.

Looking at the options, none directly say that, but the closest is option B and D.

I think the intended answer is B: protein degradation and loss of wild-type function.

But I'm not 100% sure. Alternatively, perhaps the mutant Y prevents the dimerization, so the proteins cannot move into the nucleus, but the question is about molecular phenotype, not localization.

Wait, another thought: if the mutant Y is in the dimerization domain, the mutant might form non-functional dimers with the wild-type, which might not be degraded but are non-functional. So the presence of Y would mean that the proteins are non-functional, but not necessarily degraded.

In that case, the molecular phenotype is a loss of function without protein degradation. But the options don't have that.

So perhaps the best fit is option D: protein aggregation and loss of function.

Wait, but why would the proteins aggregate? Because the dimers are non-functional and perhaps misfolded, leading to aggregation.

I think the correct answer is B) protein degradation and loss of function.

No, wait, in the presence of Y, the dimer can't form. So the proteins are either in the cytoplasm or not functioning. They might not be degraded, but the question is about molecular phenotype.

Alternatively, the mutant Y might cause the proteins to be recognized as misfolded and get degraded. So option B.

But I'm not certain. Given the options, I think the correct answer is B.


The question involves understanding the molecular effects of a dominant-negative mutation (Y) in the dimerization domain of a transcription factor. In this scenario, the transcription factor requires proper dimerization to function, and mutation Y interferes with this process. The analysis of the options is as follows:

1. **Option A: Change of protein conformation and gain-of-function phenotype**  
   This is incorrect because dominant-negative mutations typically result in a loss of function, not a gain of function. Mutation Y disrupts dimerization, which is necessary for the transcription factor to function, rather than causing a conformational change that enhances activity.

2. **Option B: Protein degradation and loss-of-function of the wild-type allele**  
   Mutation Y is a dominant-negative mutation, meaning it interferes with the function of the wild-type protein. If the mutant Y protein cannot dimerize properly, it may lead to misfolding, which could result in the protein being targeted for degradation. This would prevent the wild-type protein from functioning, leading to a loss of function. This option aligns with the idea that the mutant Y protein disrupts the wild-type protein's ability to form functional dimers, potentially leading to degradation.

3. **Option C: Loss of protein dimerization and wild-type phenotype**  
   This is incorrect because the loss of dimerization would prevent the transcription factor from functioning, resulting in a loss-of-function phenotype, not a wild-type phenotype. The presence of mutation Y would disrupt dimerization, leading to a loss of function, not a preserved wild-type phenotype.

4. **Option D: Protein aggregation and loss-of-function phenotype**  
   While protein aggregation could occur if misfolded proteins are not degraded, the question does not provide specific evidence that aggregation is the primary molecular phenotype. The dominant-negative effect of mutation Y is more likely to interfere with dimerization, leading to a loss of function without necessarily causing aggregation.

Given the analysis, the most plausible molecular phenotype is that the mutant Y protein disrupts dimerization, leading to the degradation of the proteins or their inability to function. This aligns most closely with **Option B**, as the dominant-negative effect of mutation Y likely causes the wild-type protein to lose function, possibly due to degradation.

ANSWER: B